Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Medication Adherence Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... marketers and senior management with the critical information they need to assess the global medication adherence market. Reasons to Purchase Outperform competitors using accurate up to date demand-side dynamics information. Understand how the market is ... Read More
-
Global Cardiovascular Partnering 2014-2020: Deal trends, players and financials
... in Cardiovascular partnering deals Financial deal terms for headline, upfront and royalty by stage of development Cardiovascular partnering agreement structure Cardiovascular partnering contract documents Top Cardiovascular deals by value Most active Cardiovascular dealmakers Most of ... Read More
-
Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025
... projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Market growth is driven by the rising prevalence of cancer, the rapid ... Read More
-
Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2025
... is valued at an estimated USD 529 million in 2020 and is projected to reach USD 769 million by 2025, at a CAGR of 7.8% during the forecast period. The increasing volume of surgeries and ... Read More
-
Acute Decompensated Heart Failure (ADHF) - Market Insight, Epidemiology and Market Forecast - 2030
... the Acute Decompensated Heart Failure (ADHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acute Decompensated Heart Failure (ADHF) market report provides current treatment practices, emerging ... Read More
-
Embolic Protection Devices Market - Global Outlook and Forecast 2020-2025
... due to the rising cardiovascular and neurovascular diseases across the globe. Globally, such diseases are primarily caused by several factors, including obesity, lack of physical activities, and hypertension. Epidemiological studies have reported that cardiac and ... Read More
-
Myocardial Infarction - Pipeline Review, H2 2020
... landscape. Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general ... Read More
-
Cardiovascular Drugs Investment Global Outlook 2020
... disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak. The market is then expected to recover and grow at a CAGR of -0.18% from ... Read More
-
Stroke Management Market Size By Type (Ischemic, Hemorrhagic, Transient Ischemic Attack [TIA]), By Diagnostics (Magnetic Resonance Imaging [MRI], Computed Tomography Scan [CT Scan], Electrocardiography, Carotid Ultrasound, Cerebral Angiography), By Therap
... Clipping, Embolic Coils, Flow Diverters, Aspiration Catheters), By End-use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 The stroke management ... Read More
-
Adhesion Barrier Market Research Report by Formulation (Film/Mesh, Gel, and Liquid), by Application (Abdominal general surgeries, Cardiovascular surgeries, Gynecological surgeries, Neurological surgeries, and Orthopedic surgeries), by Product - Global Fo
... Impact of COVID-19 The Global Adhesion Barrier Market is expected to grow from USD 588.46 Million in 2019 to USD 885.37 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of ... Read More
-
Cardiologists
... private practices, health care organizations, and hospitals, as well as academic, government, or research institutions. Leading institutions for cardiology and heart surgery include The Cleveland Clinic and the Mayo Clinic, both based in the US, ... Read More
-
Heart Valve Repair and Replacement Devices
... Replacement Devices estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$18.2 Billion by 2027, growing at a CAGR of 16.6% over the period 2020-2027.Replacement Devices, one of ... Read More
-
Cardiovascular Ultrasound Systems
... projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Transthoracic Echocardiogram, one of the segments analyzed in the report, is projected to ... Read More
-
Atrial Fibrillation Devices
... projected to reach a revised size of US$9.7 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. EP Ablation Catheters, one of the segments analyzed in the report, is projected ... Read More
-
Cardiovascular Catheters
... a revised size of US$11.5 Billion by 2027, growing at aCAGR of 3.8% over the period 2020-2027. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is projected to record 4.1% CAGR and ... Read More
-
Cardiology IT Workflow Solutions
... year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 7.2% over the period 2020-2027. Cloud, one of the segments analyzed in the report, is projected to ... Read More
-
Carotid Stents
... a revised size of US$3.1 Billion by 2027, growing at a CAGR of 11% over the period 2020-2027. The U.S. Market is Estimated at $406 Million, While China is Forecast to Grow at 14.5% CAGR ... Read More
-
Atrial Fibrillation - Pipeline Review, H2 2020
... landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body. Symptoms include decreased blood pressure, weakness, lightheadedness, confusion and chest pain. The predisposing factors include ... Read More
-
Myocardial Ischemia - Pipeline Review, H2 2020
... landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body ... Read More
-
Dyslipidemia - Pipeline Review, H2 2020
... is defined as elevation of the total cholesterol, the bad low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the good high-density lipoprotein (HDL) cholesterol concentration in the blood. Numerous factors and ... Read More
-
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020
... Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms ... Read More
-
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H2 2020
... 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) pipeline Target constitutes close to 40 molecules. Out of which approximately 34 molecules are developed by companies and remaining by ... Read More
-
RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)); Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Diso
... Diseases, and Other); Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others); End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals), and Geography The RNAi therapeutics market was valued at ... Read More
-
Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -
... Analysis, 2020 - 2027 Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing ... Read More
-
Europe Small Molecule Drug Delivery Market Forecast to 2027 – COVID-19 Impact and Country Analysis – by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas);
... (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Country Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The ... Read More
